fbpx

SEARCH

Low-Dose Radiotherapy for Osteoarthritis

Xstrahl's Medical Director, Dr. Richard Shaffer, recently spoke for a webinar hosted by Joint Pain Practice. He shares how low-dose radiotherapy can be used for osteoarthritis, and overviews the treatment process, risks, and efficacy. https://youtu.be/ab4iyfhN_L8...

read more

Developing an Internal Eye Shield

In this webinar, Tom Murray of Hull University Teaching Hospitals presents on developing an internal eye shield for radiotherapy. Lead eye shields are a simple yet effective solution to protect the patient’s lenses during superficial and orthovoltage radiation therapy...

read more

Xstrahl to Showcase Radiant™ Aura at AAD 2024 in San Diego

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the Maui Derm Hawaii 2024 meeting, January 22-26, 2024. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.

read more

Xstrahl to feature Radiant™ Aura at Maui Derm Hawaii 2024

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the Maui Derm Hawaii 2024 meeting, January 22-26, 2024. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.

read more

Prevention of Radiation-Induced Bladder Injury

Xstrahl in Action Pelvic radiotherapy (RT) can cause debilitating bladder toxicities. In the recent study, researchers sought methods to protect against and alleviate RT-induced late bladder injury.Publication Prevention of radiation-induced bladder injury: A murine...

read more